Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.

Zuckerman T, Ram R, Akria L, Koren-Michowitz M, Hoffman R, Henig I, Lavi N, Ofran Y, Horowitz NA, Nudelman O, Tavor S, Yeganeh S, Gengrinovitch S, Flaishon L, Tessler S, Ben Yakar R, Rowe JM.

Blood Adv. 2019 Nov 26;3(22):3740-3749. doi: 10.1182/bloodadvances.2019000468.


Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.

Vadasz Z, Kessler O, Akiri G, Gengrinovitch S, Kagan HM, Baruch Y, Izhak OB, Neufeld G.

J Hepatol. 2005 Sep;43(3):499-507.


Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165.

Gengrinovitch S, Berman B, David G, Witte L, Neufeld G, Ron D.

J Biol Chem. 1999 Apr 16;274(16):10816-22.


Vascular endothelial growth factor (VEGF) and its receptors.

Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z.

FASEB J. 1999 Jan;13(1):9-22. Review.


Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants.

Neufeld G, Cohen T, Gitay-Goren H, Poltorak Z, Tessler S, Sharon R, Gengrinovitch S, Levi BZ.

Cancer Metastasis Rev. 1996 Jun;15(2):153-8. Review. No abstract available.


Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.

Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ, Neufeld G.

J Biol Chem. 1996 Mar 8;271(10):5519-23.


Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.

Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, Levi BZ, Neufeld G.

J Biol Chem. 1995 Jun 23;270(25):15059-65.

Supplemental Content

Loading ...
Support Center